<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Comparative risk of harm associated with trazodone or atypical antipsychotic use in older adults with dementia: a retrospective cohort study</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Jennifer</forename><forename type="middle">A</forename><surname>Watt</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Tara</forename><surname>Gomes</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Susan</forename><forename type="middle">E</forename><surname>Bronskill</surname></persName>
						</author>
						<author>
							<persName><roleName>MSc</roleName><forename type="first">Anjie</forename><surname>Huang</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Peter</forename><forename type="middle">C</forename><surname>Austin</surname></persName>
						</author>
						<author>
							<persName><roleName>MD MSc</roleName><forename type="first">Joanne</forename><forename type="middle">M</forename><surname>Ho</surname></persName>
						</author>
						<author role="corresp">
							<persName><roleName>MD MSc</roleName><forename type="first">Sharon</forename><forename type="middle">E</forename><surname>Straus</surname></persName>
							<email>sharon.straus@utoronto.ca</email>
						</author>
						<title level="a" type="main">Comparative risk of harm associated with trazodone or atypical antipsychotic use in older adults with dementia: a retrospective cohort study</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">C2DF0959C8E820DBF47C5E5ADCDACF2F</idno>
					<idno type="DOI">10.1503/cmaj.180551</idno>
					<note type="submission">Accepted: Oct. 5, 2018</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:38+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>BACKGROUND:</head><p><s>Trazodone is increasingly prescribed for behavioural and psychological symptoms of dementia, but little is known about its risk of harm.</s><s>Our objective was to describe the comparative risk of falls and fractures among older adults with dementia dispensed trazodone or atypical antipsychotics.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS:</head><p><s>The study cohort included adults with dementia (excluding patients with chronic psychotic illnesses) living in long-term care and aged 66 years and older.</s><s>Data were obtained from routinely collected, linked health administrative databases in Ontario, Canada.</s><s>We compared new</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>T</head><p><s>4]<ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref> Despite the limited evidence of treatment efficacy, both antipsychotics and trazodone (an anti depressant medication) are commonly used to alleviate the behavioural and psychological symptoms of dementia. <ref type="bibr" target="#b6">7</ref></s><s>In 2013, 34% of older adults with dementia living in a long-term care facility in Ontario, Canada, were dispensed an atypical antipsychotic, and 21.3% were dispensed trazodone. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b7">8</ref></s><s>Similarly high rates of antidepressant and atypical antipsychotic use were reported among patients with dementia in the United States and Europe. <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b9">10</ref></s><s>8]<ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref> Comparatively, little is known about the risk of harm from trazodone in older adults with dementia -despite its increasing use. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9</ref></s><s>In Ontario, the prevalence of trazodone prescriptions has risen sharply, from 7.7% in 2002 to 21.3% in 2013. <ref type="bibr" target="#b2">3</ref></s><s>Randomized controlled trials (RCTs) of trazodone in patients with dementia described adverse effects, users of trazodone with new users of atypical antipsychotics (quetiapine, olanzapine or risperidone) between Dec. 1, 2009, and Dec. 31, 2015.</s><s>The primary outcome was a composite of fall or major osteoporotic fracture within 90 days of first prescription.</s><s>Secondary outcomes were falls, major osteoporotic fractures, hip fractures and allcause mortality.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS:</head><p><s>We included 6588 older adults dispensed trazodone and 2875 dispensed an atypical antipsychotic, of whom 95.2% received a low dose of these medications.</s><s>Compared with use of atypical antipsychotics, use of trazo-done was associated with similar rates of falls or major osteoporotic fractures (weighted hazard ratio [HR] 0.89, 95% confidence interval [CI] 0.73 to 1.07), major osteoporotic fracture (weighted HR 1.03, 95% CI 0.73 to 1.47), falls (weighted HR 0.91, 95% CI 0.75 to 1.11) and hip fractures (weighted HR 0.92, 95% CI 0.59 to 1.43).</s><s>Use of trazodone was associated with a lower rate of mortality (weighted HR 0.75, 95% CI 0.66 to 0.85).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTERPRETATION:</head><p><s>Trazodone is not a uniformly safer alternative to atypical antipsychotics, given the similar risk of falls and fractures among older adults with dementia.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>VULNERABLE POPULATIONS CPD</head><p><s>4]<ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref> Understanding how potential harms associated with trazodone compare with the harms associated with antipsychotics is important because we know there are risks associated with antipsychotic use in older adults. <ref type="bibr" target="#b27">28</ref></s><s>Clinicians might use trazodone to treat the behavioural and psychological symptoms of dementia instead of antipsychotics to avoid these risks.</s></p><p><s>We examined the comparative risk of the composite outcome of falls and major osteoporotic fractures, falls, major osteoporotic fractures, hip fractures and all-cause mortality among older adults with dementia dispensed trazodone or atypical antipsychotics.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>This manuscript is reported in accordance with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) and RECORD (Reporting of Studies Conducted Using Observational Routinely-collected Data) statements for the reporting of observational studies. <ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b29">30</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Setting and data sources</head><p><s>We created our cohort using the linked health administrative databases at ICES in Ontario, Canada.</s><s>Ontario has a largely publicly funded health care system, in which individuals aged 65 years or older have guaranteed housing in long-term care facilities when necessary, and universal coverage for physician services and most prescription medications.</s><s>Patient-level information was linked using an encoded version of each patient's health insurance program number. <ref type="bibr" target="#b30">31</ref></s><s>We linked data from the following databases: Ontario Drug Benefit, ICES Physician Database, Ontario Mental Health Reporting System, National Ambulatory Care Reporting System, Ontario Health Insurance Plan Database, Registered Persons Database, Discharge Abstract Database and Continuing Care Reporting System. <ref type="bibr" target="#b31">32</ref></s><s>A description of these databases is found in Appendix 1a, available at www.cmaj.ca/</s><s>lookup/suppl/doi:10.1503/cmaj.180551/-/DC1.</s><s><ref type="bibr" target="#b34">[35]</ref><ref type="bibr">[36]</ref><ref type="bibr" target="#b35">[37]</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study design</head><p><s>We implemented a retrospective cohort study design.</s><s>Our index date was the date of first prescription of an exposure or comparator drug.</s><s>We identified patients who were dispensed a study drug and had a full interRAI (International Resident Assessment Instrument) assessment within 30 days before cohort entry.</s><s>The Resident Assessment Instrument-Minimum Data Set is a validated assessment that contains information about aspects of patients' health, including independence in activities of daily living and severity of cognitive impairment. <ref type="bibr" target="#b36">38,</ref><ref type="bibr" target="#b37">39</ref></s><s>We required assessments within 30 days to ensure a close temporal relation between drug exposure and data on patients' state of health.</s><s>This cohort included adults aged 66 years or older with dementia who were living in long-term care facilities and newly dispensed oral trazodone or atypical antipsychotics (quetiapine, olanzapine or risperidone) between Dec. 1, 2009, and  Dec. 31, 2015.</s><s>We identified patients with dementia using the validated algorithm of Jaakkimainen and colleagues, and diagnostic codes from the interRAI assessment. <ref type="bibr" target="#b32">33,</ref><ref type="bibr" target="#b38">40</ref></s><s>The algorithm of Jaakkimainen and colleagues has a sensitivity of 79.3% and specificity of 99.1% for identifying dementia.</s><s>Our observation window was 90 days, which was chosen to balance the need for sufficient time for accrual of events with the need to lessen the chance of residual confounding.</s><s>The maximum follow-up date was Mar.</s><s>31, 2016.</s></p><p><s>]<ref type="bibr" target="#b40">[42]</ref> Patients in our exposure group received oral trazodone (maximum total daily dose: 300 mg) and those in our comparator group received oral quetiapine (maximum total daily dose: 300 mg), risperidone (maximum total daily dose: 3 mg) or olanzapine (maximum total daily dose: 10 mg).</s><s>Equivalency ratios were calculated as the mean of equally efficacious doses of drugs across RCTs (Appendix 1b, available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.180551/-/DC1.). <ref type="bibr" target="#b41">43,</ref><ref type="bibr" target="#b42">44</ref></s><s>e derived stabilized inverse probability of treatment weights from a propensity score model in which exposure status was regressed on a set of measured baseline covariates.</s><s>Covariates were selected for inclusion in the propensity score model based on the existing literature and clinical judgment (see Appendix 2, available at www.cmaj.ca/</s><s>lookup/suppl/doi:10.1503/cmaj.180551/-/DC1, for the variables included in the propensity score model). <ref type="bibr" target="#b43">45</ref></s><s>As a sensitivity analysis, inverse probability of treatment weights were also derived from a highdimensional propensity score model. <ref type="bibr" target="#b44">46</ref></s><s>]<ref type="bibr" target="#b47">[49]</ref> We defined our outcomes with input from 12 care partners of older adults with dementia.</s><s>Outcomes were ranked in descending order of importance from among commonly reported safety outcomes (e.g., mortality and stroke) in studies of pharmacologic treatments for the behavioural and psychologic symptoms of dementia. <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b48">50,</ref><ref type="bibr" target="#b49">51</ref></s><s>We defined our primary outcome as a composite of a fall resulting in an emergency department visit or major osteoporotic fracture.</s><s>A major osteoporotic fracture was defined as a fracture of the hip, pelvis, humerus or forearm. <ref type="bibr" target="#b50">52</ref></s><s>3]<ref type="bibr" target="#b52">[54]</ref><ref type="bibr" target="#b53">[55]</ref> Our secondary outcomes were all-cause mortality and the components of our primary outcome: falls, major osteoporotic fracture and hip fracture.</s><s>7]<ref type="bibr" target="#b56">[58]</ref> All International Classification of Diseases, 10th Revision (ICD-10) codes and algorithms used to define patients' baseline characteristics and study outcomes are found in Appendix 3, available at www.cmaj.ca/lookup/suppl/</s><s>59]<ref type="bibr" target="#b58">[60]</ref><ref type="bibr" target="#b59">[61]</ref><ref type="bibr" target="#b60">[62]</ref><ref type="bibr" target="#b61">[63]</ref><ref type="bibr" target="#b62">[64]</ref><ref type="bibr" target="#b63">[65]</ref><ref type="bibr" target="#b64">[66]</ref><ref type="bibr" target="#b65">[67]</ref><ref type="bibr" target="#b66">[68]</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>We compared baseline characteristics of patients in our exposure and comparator groups with standardized differences. <ref type="bibr" target="#b67">69</ref></s><s>Groups were considered similar if the standardized difference was less than 0.1. <ref type="bibr" target="#b68">70,</ref><ref type="bibr" target="#b69">71</ref></s><s>We reported the proportion of patients missing data for individual baseline characteristics.</s><s>Stabilized inverse probability of treatment weights were derived from the estimated propensity score.</s><s>Treatment weights were inspected for outlying values (&gt; 50). <ref type="bibr" target="#b70">72</ref></s><s>Unweighted and weighted cause-specific hazard ratios (HRs) were derived from cause-specific hazards models that accounted for the competing risk of death. <ref type="bibr" target="#b71">73,</ref><ref type="bibr" target="#b72">74</ref></s><s>We chose the cause-specific hazard model because we wanted to understand the association between our exposure and the rate of outcome in participants who were event-free and thus at risk of the event.</s><s>This addresses a primarily etiologic question. <ref type="bibr" target="#b73">75</ref></s><s>Robust standard errors were used to account for within-subject homogeneity in outcomes induced by weighting. <ref type="bibr" target="#b74">76</ref></s><s>We verified that the HR did not vary over time.</s><s>We based our primary analyses on an intentionto-treat principle whereby patients in the cohort were followed until the first of the following: outcome of interest, death or 90 days after index date.</s><s>In secondary analyses, we censored patients in the cohort if they were dispensed a drug from the other exposure group during the 90-day follow-up period.</s><s>Weighted incidence rates are reported as the number of events per 100 person-years.</s><s>Risk differences were calculated as the weight-adjusted difference in absolute risk among patients dispensed trazodone minus the absolute risk in patients dispensed atypical antipsychotics at 90 days.</s><s>Where numbers permitted, we planned to conduct subgroup analyses of outcomes based on age, sex and dementia severity.</s><s>We also planned to describe the effect of drug dose on outcomes using dose as a time-varying covariate in an unweighted Cox proportional hazards model incorporating all of the characteristics described in Appendix 2.</s></p><p><s>As a sensitivity analysis, we derived stabilized inverse probability of treatment weights from the estimated high-dimensional propensity score.</s><s>Re-weighted cause-specific HRs were derived for our primary and secondary outcomes.</s><s>Lastly, we repeated our weighted regression analyses using a subdistribution hazard model that accounted for the competing risk of death. <ref type="bibr" target="#b75">77</ref></s><s>With the subdistribution hazard model, we are estimating the association of exposure with the cumulative incidence function. <ref type="bibr" target="#b76">78</ref></s><s>Formally, the subdistribution HR compares the instantaneous rate of the outcome in the risk set of participants who are event-free or who have experienced a competing event, while the cause-specific hazard model focuses on comparing the rates of the outcome in participants who are currently event-free.</s><s>All analyses were conducted using SAS, version 9.4.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethics approval</head><p><s>This study was approved by the University of Toronto and Sunnybrook Health Sciences Centre research ethics boards.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Our cohort consisted of 9463 patients: 6588 were newly dispensed trazodone and 2875 were newly dispensed atypical anti-psychotics (Figure <ref type="figure" target="#fig_0">1</ref>).</s><s>There were no outlying stabilized inverse probability of treatment weights.</s><s>Among patients dispensed atypical antipsychotics, 275 (9.6%) were dispensed olanzapine, 1511 (52.6%) were dispensed quetiapine and 1089 (37.9%) were dispensed risperidone.</s><s>Almost all patients were dispensed a low dose of the exposure or comparator drug: 95.2% of patients were dispensed a dose that was less than or equivalent to 2.5 mg of olanzapine per day, 4.1% were dispensed a moderate dose and 0.7% were dispensed a high dose.</s><s>After applying inverse probability of treatment weights, exposure and comparator groups were similar at baseline (Table <ref type="table" target="#tab_0">1</ref>).</s><s>The mean age of patients on the date of cohort entry was 85.3 (standard deviation 7.2) years, and 68.7% were female.</s><s>In our primary analysis, patients newly dispensed trazodone experienced a similar rate of falls and major osteoporotic fractures after inverse probability of treatment weighting (cause-specific HR 0.89, 95% confidence interval [CI] 0.73 to 1.07; Table <ref type="table" target="#tab_1">2</ref>) compared with those initiating atypical antipsychotics.</s><s>We also found similar rates of our secondary outcomes of falls (cause-specific HR 0.91, 95% CI 0.75 to 1.11), major osteoporotic fractures (cause-specific HR 1.03, 95% CI 0.73 to 1.47), and hip fractures (cause-specific HR 0.92, 95% CI 0.59 to 1.43).</s><s>However, patients dispensed trazodone had a lower rate of all-cause mortality (HR 0.75, 95% CI 0.66 to 0.85).</s><s>In our tracer analysis, there was no difference in the rate of cataract surgery between new users of trazodone or atypical antipsychotics (HR 0.67, 95% CI 0.33 to 1.34).</s></p><p><s>The results of our secondary analyses were consistent with those of our primary analyses (Table <ref type="table" target="#tab_1">2</ref>).</s><s>The baseline characteristics of our cohort and our conclusions were unchanged using the high-dimensional propensity score to derive our inverse probability of treatment weights (Appendix 4, available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.180551/-/</s><s>DC1).</s><s>The subdistribution hazard analysis showed that the cumulative incidence function for falls or major osteoporotic fracture, falls, major osteoporotic fractures, and hip fractures were similar between the 2 drug groups (Appendix 5, available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.180551/-/</s><s>DC1).</s><s>We did not do our planned analysis of time-varying dose because almost all patients in our cohort were dispensed a low-dose equivalent.</s><s>We also did not conduct subgroup analyses because our sample was too small to derive meaningful effect estimates.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Interpretation</head><p><s>In this population-based study of older adults with dementia, we found that patients dispensed trazodone had a rate of falls, major osteoporotic fractures and hip fractures comparable to those of patients dispensed atypical antipsychotics; however, their rate of all-cause mortality within 90 days was significantly lower, as discussed below.</s><s>In Ontario, falls and fractures are not uncommon among residents of long-term care facilities: 2.8% had a fall resulting in an emergency department visit or hospital admission within 90 days of entering into a study cohort and 3.3% had a fracture of the hip, pelvis, wrist or humerus over a 1-year period. <ref type="bibr" target="#b77">79,</ref><ref type="bibr" target="#b78">80</ref></s><s>Among residents of Ontario long-term care facilities who were not prescribed an antipsychotic, 2.7% of residents died within 30 days and 15.1% of residents died within 180 days of cohort entry. <ref type="bibr" target="#b79">81</ref></s><s>3]<ref type="bibr" target="#b82">[84]</ref> In a cross-sectional analysis of older men living in the community, trazodone use was not associated with an increased risk of fracture; however, these men had less burden of illness than our study cohort. <ref type="bibr" target="#b82">84</ref></s><s>A study of older adults in long-term care facilities found an increased risk of fall and fracture among patients dispensed trazodone. <ref type="bibr" target="#b78">80</ref></s><s>The association between trazodone use and death among older adults with dementia was a novel finding.</s><s>Could the greater risk of death associated with atypical anti psychotic use be related to an altered cardiometabolic profile?</s><s>Although both trazodone and atypical antipsychotics have been associated with an increased risk of falls and fractures, anti psychotic use has also been associated with an increased risk of myocardial infarction and stroke in patients with dementia. <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b48">50,</ref><ref type="bibr" target="#b78">80</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Limitations</head><p><s>Despite our use of a clinically derived propensity score using detailed clinical data, the nonrandomized nature of our study means that it is possible for unmeasured confounding to influence our findings.</s><s>However, our results did not change in our sensitivity analysis, in which we implemented a highdimensional propensity score model, and the results of our primary and secondary analyses were consistent.</s><s>Because of software limitations, we were unable to estimate the cumulative incidence functions in the weighted samples.</s><s>To limit confounding from frailty and medication noncompliance, we chose a moderately to severely frail population of patients with dementia living in long-term care facilities.</s><s>This might limit the generalizability of our findings to less frail older adults outside of a longterm care setting, but frailty has prognostic importance in older adults. <ref type="bibr" target="#b83">85,</ref><ref type="bibr" target="#b84">86</ref></s><s>Our outcome of falls was limited to patients presenting to hospital. <ref type="bibr" target="#b50">52,</ref><ref type="bibr" target="#b85">87</ref></s><s>Therefore, the number of events we observed is likely an underestimate of the number of falls associated with trazodone and atypical antipsychotics; however, there should not be any differential misclassification between our exposure and comparator groups (assuming that patients in each group experienced falls of similar severity).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p><s>As clinicians move to decrease antipsychotic use, we should not consider trazodone as a uniformly safer alternative to atypical antipsychotics, because trazodone use was associated with a comparable risk of falls and major osteoporotic fractures to atypical antipsychotics -drugs associated with these adverse outcomes in our patient population. <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b27">28</ref></s><s>As appropriate prescribing campaigns target antipsychotic use in older adults with dementia, we will need to consider how these campaigns could lead to collateral changes in clinical practice. <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b16">17</ref></s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FullFigure 1 :</head><label>1</label><figDesc><div><p><s>Figure 1: Flow diagram of study cohort creation.</s><s>Note: interRAI = International Resident Assessment Instrument.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 : Selected baseline characteristics* of older adults dispensed trazodone or atypical antipsychotics</head><label>1</label><figDesc></figDesc><table><row><cell></cell><cell cols="2">No. (%) of participants †</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>Crude</cell><cell>Weighted</cell></row><row><cell></cell><cell>Trazodone</cell><cell>Atypical antipsychotics</cell><cell>standardized</cell><cell>standardized</cell></row><row><cell>Characteristic</cell><cell>n = 6588</cell><cell>n = 2875</cell><cell>difference</cell><cell>difference</cell></row><row><cell>Demographic characteristics</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Age, yr, mean ± SD</cell><cell>85.48 ± 7.22</cell><cell>85.00 ± 7.07</cell><cell>0.07</cell><cell>0.02</cell></row><row><cell>Female sex</cell><cell>4594 (69.7)</cell><cell>1908 (66.4)</cell><cell>0.07</cell><cell>0.01</cell></row><row><cell>Weight, kg, mean ± SD</cell><cell>65.86 ± 29.10</cell><cell>65.17 ± 29.99</cell><cell>0.02</cell><cell>&lt; 0.01</cell></row><row><cell>Income quintile</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Missing</cell><cell>66 (1.0)</cell><cell>36 (1.3)</cell><cell>0.02</cell><cell>0.01</cell></row><row><cell>1 (lowest)</cell><cell>1549 (23.5)</cell><cell>663 (23.1)</cell><cell>0.01</cell><cell>0.01</cell></row><row><cell>2</cell><cell>1274 (19.3)</cell><cell>532 (18.5)</cell><cell>0.02</cell><cell>&lt; 0.01</cell></row><row><cell>3</cell><cell>1335 (20.3)</cell><cell>600 (20.9)</cell><cell>0.01</cell><cell>0.01</cell></row><row><cell>4</cell><cell>1254 (19.0)</cell><cell>508 (17.7)</cell><cell>0.04</cell><cell>0.01</cell></row><row><cell>5 (highest)</cell><cell>1110 (16.8)</cell><cell>536 (18.6)</cell><cell>0.05</cell><cell>&lt; 0.01</cell></row><row><cell>Dependency in ADLs, mean ± SD</cell><cell>5.20 ± 1.33</cell><cell>5.35 ± 1.16</cell><cell>0.12</cell><cell>0.03</cell></row><row><cell>Health care use</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Prescriptions, mean ± SD</cell><cell>19.45 ± 9.97</cell><cell>17.63 ± 9.68</cell><cell>0.18</cell><cell>0.01</cell></row><row><cell>Emergency department visits, mean ± SD</cell><cell>1.52 ± 2.85</cell><cell>1.39 ± 1.95</cell><cell>0.05</cell><cell>0.01</cell></row><row><cell>Inpatient hospital admissions, mean ± SD</cell><cell>0.66 ± 1.00</cell><cell>0.58 ± 0.95</cell><cell>0.09</cell><cell>0.02</cell></row><row><cell>Johns Hopkins ACG (version 10) ADGs</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>0-5</cell><cell>1601 (24.3)</cell><cell>812 (28.2)</cell><cell>0.09</cell><cell>&lt; 0.01</cell></row><row><cell>6-10</cell><cell>2173 (33.0)</cell><cell>965 (33.6)</cell><cell>0.01</cell><cell>&lt; 0.01</cell></row><row><cell>≥ 11</cell><cell>2814 (42.7)</cell><cell>1098 (38.2)</cell><cell>0.09</cell><cell>&lt; 0.01</cell></row><row><cell>Medications</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Anticoagulants</cell><cell>1498 (22.7)</cell><cell>515 (17.9)</cell><cell>0.12</cell><cell>0.01</cell></row><row><cell>Hypoglycemic agents</cell><cell>1416 (21.5)</cell><cell>570 (19.8)</cell><cell>0.04</cell><cell>0.03</cell></row><row><cell>Antihypertensives</cell><cell>4606 (69.9)</cell><cell>1895 (65.9)</cell><cell>0.09</cell><cell>0.02</cell></row><row><cell>Antilipemics</cell><cell>3015 (45.8)</cell><cell>1252 (43.5)</cell><cell>0.04</cell><cell>0.01</cell></row><row><cell>Glucocorticoids</cell><cell>607 (9.2)</cell><cell>205 (7.1)</cell><cell>0.08</cell><cell>0.02</cell></row><row><cell>Hormone therapies</cell><cell>150 (2.3)</cell><cell>32 (1.1)</cell><cell>0.09</cell><cell>0.02</cell></row><row><cell>Osteoporosis treatments</cell><cell>1551 (23.5)</cell><cell>663 (23.1)</cell><cell>0.01</cell><cell>0.01</cell></row><row><cell>Antiparkinsonian agents</cell><cell>501 (7.6)</cell><cell>220 (7.7)</cell><cell>0.00</cell><cell>0.01</cell></row><row><cell>Pain medications</cell><cell>2892 (43.9)</cell><cell>1106 (38.5)</cell><cell>0.11</cell><cell>0.02</cell></row><row><cell>Psychoactive agents</cell><cell>4842 (73.5)</cell><cell>2273 (79.1)</cell><cell>0.13</cell><cell>0.01</cell></row><row><cell>Medical history</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Alcohol use</cell><cell>329 (5.0)</cell><cell>128 (4.5)</cell><cell>0.03</cell><cell>0.02</cell></row><row><cell>Cardiac arrhythmias</cell><cell>1838 (27.9)</cell><cell>683 (23.8)</cell><cell>0.09</cell><cell>0.01</cell></row><row><cell>Cerebrovascular disease</cell><cell>1526 (23.2)</cell><cell>607 (21.1)</cell><cell>0.05</cell><cell>0.01</cell></row><row><cell>Delusions or hallucinations</cell><cell>251 (3.8)</cell><cell>266 (9.3)</cell><cell>0.22</cell><cell>0.01</cell></row><row><cell>Depression</cell><cell>2072 (31.5)</cell><cell>871 (30.3)</cell><cell>0.03</cell><cell>0.01</cell></row><row><cell>Diabetes mellitus</cell><cell>2285 (34.7)</cell><cell>947 (32.9)</cell><cell>0.04</cell><cell>&lt; 0.01</cell></row><row><cell>Falls</cell><cell>1619 (24.6)</cell><cell>679 (23.6)</cell><cell>0.02</cell><cell>0.01</cell></row><row><cell>Major osteoporotic fracture</cell><cell>975 (14.8)</cell><cell>373 (13.0)</cell><cell>0.05</cell><cell>0.02</cell></row><row><cell>Ischemic heart disease</cell><cell>1774 (26.9)</cell><cell>678 (23.6)</cell><cell>0.08</cell><cell>0.01</cell></row><row><cell>Hypertension</cell><cell>5564 (84.5)</cell><cell>2296 (79.9)</cell><cell>0.12</cell><cell>0.01</cell></row><row><cell>Parkinsonism</cell><cell>481 (7.3)</cell><cell>212 (7.4)</cell><cell>0.00</cell><cell>0.01</cell></row><row><cell>Wheelchair ambulation</cell><cell>3676 (55.8)</cell><cell>1364 (47.4)</cell><cell>0.17</cell><cell>0.01</cell></row></table><note><p><s>Note: ACG = Adjusted Clinical Groups System, ADGs = Aggregated Diagnosis Groups, ADLs = activities of daily living, SD = standard deviation.</s><s>*See Appendix 2 (available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.180551/-/DC1) for the complete baseline characteristics of our study cohort.</s><s>†Unless stated otherwise.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 : Primary and secondary analyses of the comparative risk of primary and secondary outcomes for new users of trazodone versus atypical antipsychotics within 90 days Outcome Crude HR (95% CI) Weighted Cause-specific HR (95% CI) Events/100 person-years Risk difference, % (95% CI) Trazodone Atypical antipsychotic Primary intention-to-treat analyses</head><label>2</label><figDesc></figDesc><table><row><cell>Fall or major osteoporotic fracture</cell><cell>0.71 (0.60 to 0.85)</cell><cell>0.89 (0.73 to 1.07)</cell><cell>23</cell><cell>25</cell><cell>-0.5 (-1.5 to 0.5)</cell></row><row><cell>All-cause mortality</cell><cell>0.78 (0.70 to 0.86)</cell><cell>0.75 (0.66 to 0.85)</cell><cell>60</cell><cell>77</cell><cell>-4.3 (-6.0 to -2.6)</cell></row><row><cell>Fall</cell><cell>0.72 (0.60 to 0.86)</cell><cell>0.91 (0.75 to 1.11)</cell><cell>22</cell><cell>24</cell><cell>-0.3 (-1.4 to 0.7)</cell></row><row><cell>Major osteoporotic fracture</cell><cell>0.81 (0.59 to 1.12)</cell><cell>1.03 (0.73 to 1.47)</cell><cell>8</cell><cell>7</cell><cell>0.1 (-0.5 to 0.7)</cell></row><row><cell>Hip fracture</cell><cell>0.72 (0.48 to 1.08)</cell><cell>0.92 (0.59 to 1.43)</cell><cell>5</cell><cell>5</cell><cell>-0.06 (-0.5 to 0.4)</cell></row><row><cell>Cataract surgery</cell><cell>0.86 (0.44 to 1.67)</cell><cell>0.67 (0.33 to 1.34)</cell><cell>2</cell><cell>3</cell><cell>-0.1 (-0.4 to 0.1)</cell></row><row><cell cols="2">Secondary analyses (censoring on switching exposure group)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Fall or major osteoporotic fracture</cell><cell>0.67 (0.56 to 0.81)</cell><cell>0.84 (0.69 to 1.02)</cell><cell>21</cell><cell>24</cell><cell>-0.8 (-1.8 to 0.2)</cell></row><row><cell>All-cause mortality</cell><cell>0.78 (0.71 to 0.85)</cell><cell>0.80 (0.73 to 0.89)</cell><cell>87</cell><cell>105</cell><cell>-4.4 (-6.3 to -2.5)</cell></row><row><cell>Fall</cell><cell>0.68 (0.57 to 0.82)</cell><cell>0.86 (0.71 to 1.05)</cell><cell>20</cell><cell>23</cell><cell>-0.6 (-1.6 to 0.4)</cell></row><row><cell>Major osteoporotic fracture</cell><cell>0.74 (0.53 to 1.03)</cell><cell>0.94 (0.65 to 1.34)</cell><cell>7</cell><cell>7</cell><cell>-0.07 (-0.6 to 0.5)</cell></row><row><cell>Hip fracture</cell><cell>0.66 (0.43 to 0.99)</cell><cell>0.84 (0.53 to 1.32)</cell><cell>4</cell><cell>5</cell><cell>-0.2 (-0.6 to 0.3)</cell></row></table><note><p><s>Note: CI = confidence interval, HR = hazard ratio.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">CMAJ | NOVEMBER 26, 2018 | VOLUME 190 | ISSUE 47 E1381</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The funders had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.</s><s>Parts of this material are based on data and information compiled and provided by the Canadian Institute for Health Information (CIHI).</s><s>However, the analyses, conclusions, opinions and statements expressed herein are those of the authors, and not necessarily those of CIHI.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data sharing:</head><p><s>The data set from this study is held securely in coded form at ICES.</s><s>Although data-sharing agreements prohibit ICES from making the data set publicly available, access may be granted to those who meet prespeci-fied criteria for confidential access, available at www.ices.on.ca/DAS.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements:</head><p><s>The authors thank Dr. Zahra Goodarzi for her help in conceptualizing our stakeholder engagement survey.</s><s>The authors also thank the following people for completing our survey: Dr. Camilla Wong, Ms. Mary-Anne Lee, Ms. Joanna Stanley, Ms. Denise Watt, Ms. Hazel Sebastian, Dr. Marie Patton, Ms. Loralee Fox, Ms. Junyan Shi, Dr. Jayna Holroyd-Leduc and Dr. David Hogan.</s><s>The authors thank Dr. Andrea Tricco and Dr. Areti-Angeliki Veroniki for their ongoing contributions to the completion of Dr. Jennifer Watt's doctoral thesis, of which this manuscript is a component.</s><s>The authors thank Brogan Inc., Ottawa, for use of its Drug Product and Therapeutic Class Database.</s></p><p><s>Disclaimer: This study was supported by ICES, which is funded by an annual grant from the Ontario MOHLTC.</s><s>The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources.</s><s>No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">Alzheimer&apos;s disease: highlights from the Canadian Chronic Disease Surveillance System. Ottawa: Public Health Agency of Canada</title>
		<author>
			<persName><forename type="first">Canada</forename><surname>Dementia In</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Ottawa: Canadian Institute for Health Information</title>
	</analytic>
	<monogr>
		<title level="m">CCRS continuing care reporting system: profile of residents in continuing care facilities 2016-2017</title>
				<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Changing pattern of sedative use in older adults: a population-based cohort study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Iaboni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Bronskill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Reynolds</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drugs Aging</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="523" to="533" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Trends in the prevalence of antipsychotic drug use among patients with Alzheimer&apos;s disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study</title>
		<author>
			<persName><forename type="first">C</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rietbrock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">e002080</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Exposure to psychotropics in the French older population living with dementia: a nationwide population-based study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Breining</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bonnet-Zamponi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zerah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Geriatr Psychiatry</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="750" to="760" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Nursing home staff attitudes towards residents with dementia: strain and satisfaction with work</title>
		<author>
			<persName><forename type="first">H</forename><surname>Brodaty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Draper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L-F</forename><surname>Low</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Adv Nurs</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="583" to="590" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Assessment and management of behavioral and psychological symptoms of dementia</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Kales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Gitlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Lyketsos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">350</biblScope>
			<biblScope unit="page">369</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Trends in psychotropic dispensing among older adults with dementia living in long-term care facilities: 2004-2013</title>
		<author>
			<persName><forename type="first">A</forename><surname>Vasudev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Z</forename><surname>Shariff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Geriatr Psychiatry</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1259" to="1269" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Trazodone utilization among the elderly in Spain. A population-based study</title>
		<author>
			<persName><forename type="first">Macías</forename><surname>Saint-Gerons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Huerta</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Garcia</forename><surname>Poza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Psiquiatr Salud Ment</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="208" to="215" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Trends in off-label use of second-generation antipsychotics in the Medicare population from</title>
		<author>
			<persName><forename type="first">J</forename><surname>Driessen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Baik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychiatr Serv</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="898" to="903" />
			<date type="published" when="2006">2006 to 2012. 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Antipsychotic drug use and mortality in older adults with dementia</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Gill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Bronskill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S-Lt</forename><surname>Normand</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="775" to="786" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Myocardial infarction risk and antipsychotics use revisited: a meta-analysis of 10 observational studies</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Hsu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1544" to="1555" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Antipsychotics and the risk of aspiration pneumonia in individuals hospitalized for nonpsychiatric conditions: a cohort study</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Herzig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Lasalvia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Naidus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Geriatr Soc</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="2580" to="2586" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title level="m" type="main">Looking for balance: antipsychotic medication use in Ontario long-term care homes. Toronto: Health Quality Ontario</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title level="m" type="main">Antipsychotic use in the elderly: final consolidated report. Toronto: Ontario Drug Policy Research Network</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">The global prevalence of dementia: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Prince</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bryce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Albanese</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alzheimers Dement</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="63" to="75" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>e2</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Treating disruptive behaviour in people with dementia</title>
	</analytic>
	<monogr>
		<title level="m">Canadian Geriatrics Society</title>
				<meeting><address><addrLine>Markham (ON; Choosing Wisely Canada</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title level="m" type="main">Five things physicians and patients should question. Philadelphia: American Psychiatric Association (Choosing Wisely)</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<monogr>
		<title level="m" type="main">Ten things clinicians and patients should question</title>
		<imprint>
			<date type="published" when="2015">2015</date>
			<publisher>American Geriatrics Society (Choosing Wisely</publisher>
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults</title>
	</analytic>
	<monogr>
		<title level="j">J Am Geriatr Soc</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="2227" to="2246" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>American Geriatrics Society Beers Criteria Update Expert Panel</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">I</forename><surname>Reus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Fochtmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Eyler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">173</biblScope>
			<biblScope unit="page" from="543" to="546" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title level="m" type="main">Dementia: Assessment, management and support for people living with dementia and their carers (draft for consultation)</title>
		<imprint>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note>London (UK): National Institute for Health and Care Excellence</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Treatment of agitation in AD: a randomized, placebo-controlled clinical trial</title>
		<author>
			<persName><forename type="first">L</forename><surname>Teri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Logsdon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Peskind</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1271" to="1278" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebocontrolled study</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Camargos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Louzada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Quintas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Geriatr Psychiatry</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1565" to="1574" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Sultzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Gunay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Geriatr Psychiatry</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="60" to="69" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">A pilot placebo-controlled study of trazodone and buspirone in Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Lawlor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Radcliffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Molchan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Geriatr Psychiatry</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="55" to="59" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Frontotemporal dementia: a randomised, controlled trial with trazodone</title>
		<author>
			<persName><forename type="first">F</forename><surname>Lebert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Stekke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hasenbroekx</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dement Geriatr Cogn Disord</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="355" to="359" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Falls and fractures with atypical antipsychotic medication use: a population-based cohort study</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Fraser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Naylor</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="page" from="450" to="452" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">The reporting of studies conducted using observational routinely-collected health data (RECORD) statement</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">I</forename><surname>Benchimol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Smeeth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Guttmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Med</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">e1001885</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies</title>
		<author>
			<persName><forename type="first">E</forename><surname>Von Elm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Egger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Surg</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1495" to="1499" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title level="m" type="main">Canadian Institute for Health Information Discharge Abstract Database: a validation study. Toronto: Institute for Clinical Evaluative Sciences</title>
		<author>
			<persName><forename type="first">D</forename><surname>Juurlink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Preyra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Croxford</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<monogr>
		<title level="m" type="main">Available: www.interrai.org (accessed</title>
		<imprint>
			<date type="published" when="2017">2018 Oct. 17</date>
		</imprint>
	</monogr>
	<note>Ann Arbor (MI)</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Validating diagnostic information on the minimum data set in Ontario hospital-based long-term care</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">P</forename><surname>Wodchis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Naglie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Teare</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Care</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="882" to="887" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Coding accuracy of administrative drug claims in the Ontario Drug Benefit database</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>O'brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sellors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Can J Clin Pharmacol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="67" to="71" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">The national ambulatory care reporting system: factors that affect the quality of its emergency data</title>
		<author>
			<persName><forename type="first">D</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Richards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chapman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Raina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Torrance-Rynard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Inform Qual</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="751" to="774" />
			<date type="published" when="2002">2008. 2002</date>
		</imprint>
	</monogr>
	<note>Health Serv Res</note>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title level="m" type="main">Ontario Mental Health Reporting System, data quality documentation. Ottawa: Canadian Institute for Health Information</title>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Indirect and mixed-treatment comparison, network, or multipletreatments analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool</title>
		<author>
			<persName><forename type="first">G</forename><surname>Salanti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Res Synth Methods</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="80" to="97" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Reliability of the interRAI suite of assessment instruments: a 12-country study of an integrated health information system</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Hirdes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ljunggren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Morris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Serv Res</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">277</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Identification of physiciandiagnosed Alzheimer&apos;s disease and related dementias in population-based administrative data: a validation study using family physicians&apos; electronic medical records</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Jaakkimainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Bronskill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Tierney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Alzheimers Dis</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="337" to="349" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Validation of a population-based algorithm to detect chronic psychotic illness</title>
		<author>
			<persName><forename type="first">P</forename><surname>Kurdyak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Green</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Can J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="362" to="368" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Comparison of the diagnostic accuracy of the Cognitive Performance Scale (minimum data set) and the Mini-Mental State Exam for the detection of cognitive impairment in nursing home residents</title>
		<author>
			<persName><forename type="first">L</forename><surname>Paquay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>De Lepeleire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Schoenmakers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Geriatr Psychiatry</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="286" to="293" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Dose equivalence of the antipsychotic drugs</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Davis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Psychiatr Res</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="65" to="69" />
			<date type="published" when="1974">1974</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Dose equivalents for second-generation antipsychotic drugs: the Classical Mean Dose method</title>
		<author>
			<persName><forename type="first">S</forename><surname>Leucht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Samara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Heres</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Schizophr Bull</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1397" to="1402" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Austin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Grootendorst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Andersen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stat Med</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="734" to="753" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">High-dimensional propensity score adjustment in studies of treatment effects using health care claims data</title>
		<author>
			<persName><forename type="first">S</forename><surname>Schneeweiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Rassen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Glynn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Epidemiology</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="512" to="522" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">MDS Cognitive Performance Scale</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Fries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Mehr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Gerontol</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="M174" to="M182" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">The aggressive behavior scale: a new scale to measure aggression based on the minimum data set</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Perlman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Hirdes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Geriatr Soc</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="2298" to="2303" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Development of a minimum data setbased depression rating scale for use in nursing homes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Burrows</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Simon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Age Ageing</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="165" to="172" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Gill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Rochon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Herrmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">330</biblScope>
			<biblScope unit="page">445</biblScope>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia</title>
		<author>
			<persName><forename type="first">H</forename><surname>Brodaty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ames</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Snowdon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="134" to="143" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">The risk of fall and fracture with the initiation of a prostate-selective alpha antagonist: a population-based cohort study</title>
		<author>
			<persName><forename type="first">B</forename><surname>Welk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mcarthur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Fraser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">351</biblScope>
			<biblScope unit="page">5398</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Using administrative data to track fall-related ambulatory care services in the Veterans Administration Healthcare system</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Luther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>French</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Powell-Cope</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Aging Clin Exp Res</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="412" to="418" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Using medical services claims to assess injuries in the elderly: sensitivity of diagnostic and procedure codes for injury ascertainment</title>
		<author>
			<persName><forename type="first">R</forename><surname>Tamblyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Reid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mayo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Epidemiol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="183" to="194" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Algorithms can be used to identify fragility fracture cases in physician-claims databases</title>
		<author>
			<persName><forename type="first">S</forename><surname>Jean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Candas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Belzile</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Osteoporos Int</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="483" to="501" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Healthy user and related biases in observational studies of preventive interventions: a primer for physicians</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Shrank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Patrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Brookhart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Gen Intern Med</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="546" to="550" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study</title>
		<author>
			<persName><forename type="first">T</forename><surname>Antoniou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Macdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hollands</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CMAJ Open</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="E166" to="E171" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Influenza morbidity and mortality in elderly patients receiving statins: a cohort study</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Kwong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Redelmeier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">e8087</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Assessing the validity of using administrative data to identify patients with epilepsy</title>
		<author>
			<persName><forename type="first">K</forename><surname>Tu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Jaakkimainen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Epilepsia</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="335" to="343" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Accuracy of administrative data for the coding of acute stroke and TIAs</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mondor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Porter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Can J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="765" to="773" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Hux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ivis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Flintoft</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="512" to="516" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Validation of physician billing and hospitalization data to identify patients with ischemic heart disease using data from the Electronic Medical Record Administrative data Linked Database (EMRALD)</title>
		<author>
			<persName><forename type="first">K</forename><surname>Tu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mitiku</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Can J Cardiol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="e225" to="228" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Accuracy of administrative databases in identifying patients with hypertension</title>
		<author>
			<persName><forename type="first">K</forename><surname>Tu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z-L</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Open Med</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="e18" to="26" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">A validation study of administrative data algorithms to identify patients with parkinsonism with prevalence and incidence trends</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Butt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Young</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroepidemiology</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="28" to="37" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Accuracy of Canadian health administrative databases in identifying patients with rheumatoid arthritis: a validation study using the medical records of rheumatologists</title>
		<author>
			<persName><forename type="first">J</forename><surname>Widdifield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bernatsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Paterson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Care Res (Hoboken)</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="1582" to="1591" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Osteoporosis quality indicators using healthcare utilization data</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Cadarette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Jaglal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Raman-Wilms</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Osteoporos Int</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1335" to="1342" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Identifying cases of congestive heart failure from administrative data: a validation study using primary care patient records</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Schultz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Rothwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chronic Dis Inj Can</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="160" to="166" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Austin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Van Walraven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">P</forename><surname>Wodchis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Canada. Med Care</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="932" to="939" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Austin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Stuart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stat Med</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="3661" to="3679" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Austin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stat Med</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="3083" to="3107" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Austin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Commun Stat Simul Comput</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="1228" to="1234" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Weight trimming and propensity score weighting</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lessler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Stuart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">e18174</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Regression models and life-tables</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Cox</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J R Stat Soc [Ser A</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="187" to="220" />
			<date type="published" when="1972">1972</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Discrete-time methods for the analysis of event histories</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Allison</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sociol Methodol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="61" to="98" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Introduction to the analysis of survival data in the presence of competing risks</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Austin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Fine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="601" to="609" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Austin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stat Med</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="5642" to="5655" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">A proportional hazards model for the subdistribution of a competing risk</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Fine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Gray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Stat Assoc</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="496" to="509" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Practical recommendations for reporting Fine-Gray model analyses for competing risk data</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Austin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Fine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stat Med</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="4391" to="4400" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Comparative trends in incident fracture rates for all long-term care and community-dwelling seniors in Ontario, Canada</title>
		<author>
			<persName><forename type="first">A</forename><surname>Papaioannou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ioannidis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Osteoporos Int</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="887" to="897" />
			<date type="published" when="2002">2002-2012. 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Association between antidepressants and fall-related injuries among long-term care residents</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Macri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Iaboni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Kirkham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Geriatr Psychiatry</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1326" to="1336" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Antipsychotic drug use and mortality in older adults with dementia</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Gill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Bronskill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S-Lt</forename><surname>Normand</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="page" from="775" to="786" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Non-tricyclic and non-selective serotonin reuptake inhibitor antidepressants and recurrent falls in frail older women</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Naples</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Kotlarczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Perera</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Geriatr Psychiatry</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1221" to="1227" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Antidepressant use and risk of adverse outcomes in older people: population-based cohort study</title>
		<author>
			<persName><forename type="first">C</forename><surname>Coupland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dhiman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Morriss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">343</biblScope>
			<biblScope unit="page">4551</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Haney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bks</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Diem</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="page" from="1246" to="1251" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">A global clinical measure of fitness and frailty in elderly people</title>
		<author>
			<persName><forename type="first">K</forename><surname>Rockwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Macknight</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CMAJ</title>
		<imprint>
			<biblScope unit="volume">173</biblScope>
			<biblScope unit="page" from="489" to="495" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Frailty in older adults: evidence for a phenotype</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Fried</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Tangen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Walston</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Gerontol A Biol Sci Med Sci</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="M146" to="M156" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">The risk of falls on initiation of antihypertensive drugs in the elderly</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Butt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mamdani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Austin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Osteoporos Int</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="2649" to="2657" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
